Thus, blocking IL6 production by nonsteroidal anti-inflammatory drugs or IL6 neutralizing monoclonal antibody in a mouse model of cancer associated cachexia reduces the severity of wasting and suppresses the browning capacity of subcutaneous WAT. This evidence concerns the gene IL6 and Cachexia.